This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Inno Biosciences, S.p.a., Maqui Newlife S.a.. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2020
Title: Rafael Burgos: Innovator in Anthocyanidin Compositions and Multiple Sclerosis Therapy
Introduction: Rafael Burgos is a noted inventor based in Valdivia, Chile, renowned for his contributions to the field of medicinal compounds. With two patents to his name, his research and inventions focus on innovative compositions that leverage anthocyanidins and their therapeutic potential.
Latest Patents: Rafael Burgos has developed several groundbreaking patents. His first patent involves compositions that include anthocyanidins, specifically rich blends of delphinidins sourced from berries. These compositions also have the potential to include andrographolides and various combinations of myrtillin, quercetin, or caffeoyl quinic derivatives alongside proanthocyanidins.
The second patent focuses on a combination therapy that enhances the effectiveness of interferon for treating multiple sclerosis. The innovation suggests that the concurrent administration of a specific compound can significantly potentiate the treatment's effectiveness for demyelinating diseases.
Career Highlights: Throughout his career, Rafael has worked with notable companies, including Maqui Newlife and Inno Biosciences. His expertise and inventions reflect a commitment to improving health outcomes through innovative research.
Collaborations: Rafael has collaborated with talented coworkers, including Juan Hancke and Evelyn Jara. Together, they contribute to the dynamic field of medicinal research and innovation, aimed at creating impactful health solutions.
Conclusion: Rafael Burgos exemplifies the spirit of innovation and dedication to advancing medical treatments. His patents in anthocyanidin compositions and combination therapies are a testament to his expertise and commitment to enhancing human health. As he continues his work, the potential for further advancements in the field remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile